Skip to content

Real World Study of Yiqifumai Prescription in Treating Heart Failure

Real World Study of Yiqifumai Prescription in Treating Heart Failure

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000124
Enrollment
Unknown
Registered
2024-07-14
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

YQFM group:Yiqifumai injection

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for heart failure; Age =18 years old, gender unlimited; NYHA cardiac function Grade II to IV

Exclusion criteria

Exclusion criteria: 1.Complicated with acute myocardial infarction (within 2 months), constrictive pericarditis, acute cerebrovascular accident, acute myocarditis, cardiogenic shock, congenital heart disease, primary severe valvular disease, symptomatic hypotension, severe arrhythmia and hemodynamic changes; 2.There are serious endocrine diseases such as malignant tumor, severe hepatic and renal insufficiency, primary disease of blood system, or diabetes with serious complications, hyperthyroidism, etc.

Design outcomes

Primary

MeasureTime frame
the dosage of YQFM;Readmissions within 1 year;the solvent of YQFM;Diagnosis;LVEF;FS;the combination medications of YQFM;Electrocardiogram;BNP;LVEDD;the administration of YQFM;CRP;LVESD;

Secondary

MeasureTime frame
Solar term;Inpatient department;admission to hospital;Liver function;Admission condition;Renal function;Baseline Characterization;

Countries

China

Contacts

Public ContactShichao Lv

irst Teaching Hospital of Tianjin University of Traditional Chinese Medicine

372272027@qq.com13920127740

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026